U.S. markets open in 5 hours 31 minutes

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
207.79-0.65 (-0.31%)
At close: 4:00PM EST
Sign in to post a message.
  • N
    New
    I don't understand what Mr Market is doing with this stock. Great product. Market leader in CF. Highly profitable with a more diversified pipeline of drugs. Working closely with CRSPR. There's no reason why this stock is not having any momentum. Wallstreet bets should YOLO $VRTX and crush the shorts
  • R
    Roman
    Opened position @ 212$ and still not clear why price is so low? Did I buy with 30% discout? How is possible wall street valuate it so low? What is the catch?
  • V
    Von
    I spent my last savings to get 5 shares of this company. When the $1400 checks arrive I will spend half on food and half on more shares. I shop at Trader Joe’s to save on groceries.
  • R
    Ryan
    (currently on the sidelines, close to pulling the trigger). The stock seems a little too good to be true. its PROFITABLE. EPS is over 10, PE ratio is 20.... arguably the leader in treatments for CF.... what gives? market cap should be almost double! or at least 85B.... honestly I am asking, what's the catch with this one? has the market really just overlooked it???? is there some anticipated bad news/data that's expected soon thats caked in???? somebody help me out here, I cant find anything to justify the discount.
    Neutral
  • c
    chad
    disappointed nothing new in the news. sitting on a balance sheet with no prospects is not what the markets are looking for . do not have much for shares but . . . . may have to dump them and go shopping . .. cannot see this increasing by may. IMO
    Neutral
  • S
    Sarah
    Little/no debt...a pipeline..a link up with Crispr and personal experience of the wonderful CF drug...may take a little time but in for the long haul
    Bullish
  • g
    gary
    Vertex is back to a firm base as I have reported weeks ago.
    Now I'll watch the base number to hold or not. If it holds with more markets going down I'll buy more. If not I'll wait for a new base to form.
  • D
    Darrell
    What’s up with this AH rise ?
  • s
    stocktargetadvisor
    $VRTX
    Upgrades Robert W Baird Outperform USD 220 » USD 252
  • R
    Rob
    Should be $260 minimum
  • S
    Sarah
    Im in the UK. My niece has CF the Vertex drug has been a game changer!
  • A
    Anonymous
    It appears the market is rotating out of small cap growth stocks into large cap value stocks due to interest rate fears. This is HUGE for VRTX. A great buying opportunity!
    Bullish
  • S
    Simon
    Started a position today. Why not for a strong company on a big discount
    Bullish
  • L
    Luis
    Hopefully tomorrow at the Conference they’ll give us good news on the pipeline. Will see
  • K
    K B B
    Let's run up to 220 again ... hopefully 3rd time is a charm for a breakout in the charts
  • j
    joe
    Rishma has zero vision and no long term strategy. It is approaching one year since her taking over and look what has happened to share holder value. Numbers don’t lie and new CEO’s that have been promoted beyond their competence level get exposed. As a leader you need to say more than we are looking for acquisitions!,,,
  • n
    none
    This is a great momentum stock, except most people prefer momentum in the other direction.
  • M
    Maxim
    Any news from conference?
  • D
    David
    I have a position as well at around the same price point. Lowest price target on this among covering analysts is 250$ a share. It is considered undervalued. That said, the downside is that Wall Street really sees this stock as stagnant and desperately in need of a catalyst. Right now, it’s a one trick pony with the Cystic Fibrosis drug therapies. I would not hold onto this forever. If I don’t start to see movement in the next few months, I will put that money something else.
    Neutral
  • Y
    Your
    Is 1300 shares enough?
    Bullish